ascopubs.org2d
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Over the past 15 years, the landscape ...
ascopubs.org3d
The role of stereotactic radiotherapy in brain metastases from gastrointestinal cancer.
A phase 1 trial of folinic acid, fluorouracil, oxaliplatin, bevacizumab, botensilimab, balstilimab (FOLFOX-3B) in microsatellite stable metastatic colorectal cancer. Phase I/II trial of encorafenib, ...
ascopubs.org3d
The prevalence and prognostic significance of KRAS G12C mutation in metastatic colorectal cancer.
Deep learning–powered analysis of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does ...
ascopubs.org4d
Disparities in stage of diagnosis of colon cancer: Differences by Hispanic background, race, and ethnicity.
Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver ...
ascopubs.org4d
Comprehensive analysis of socioeconomic and clinical factors contributing to treatment delay in early-onset colorectal cancer.
Comprehensive analysis of Native Hawaiians and other Pacific Islanders with early-onset colorectal cancer. Univariate and multivariate analysis of time from diagnosis to treatment.
ascopubs.org4d
LAPIS: Randomized phase 3 trial of chemotherapy (CTX) with and without pamrevlumab (PAM) for locally advanced pancreatic cancer (LAPC).
Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA) as first- and second-line therapy in metastatic pancreatic cancer (mPDAC): Results from Precision Promise (PrP ...
ascopubs.org4d
Real-world evidence on genomic profiles and survival outcomes in patients with HER2-positive metastatic colorectal cancer.
Effectiveness of anti-epidermal growth factor receptor agents in elderly patients (age ≥ 70 years) with RAS wild-type metastatic colorectal cancer: Nationwide real-world data. This is an ASCO Meeting ...
ascopubs.org4d
Prognosis of signet ring cell (SRC) gastric carcinoma (GC) compared with other histological subtypes.
Prognostic impact of postoperative complications after neoadjuvant therapy followed by esophagectomy for esophageal cancer: An exploratory analysis of phase III trial JCOG1109.
ascopubs.org4d
BREAKWATER: Analysis of first-line encorafenib + cetuximab + chemotherapy in BRAF V600E-mutant metastatic colorectal cancer.
Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort. Final analysis of ...
ascopubs.org4d
Disparities in incidence and mortality of colorectal cancer in Appalachian Kentucky.
Comprehensive analysis of socioeconomic and clinical factors contributing to treatment delay in early-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
ascopubs.org4d
Trends in surgery and overall survival in non-metastatic anal cancer: A population-based analysis.
Trends and disparities in palliative care utilization among patients with anal cancer: A ten-year retrospective study. Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ ...
ascopubs.org4d
Association between visceral adipose tissue radiodensity and overall survival among older adults with colorectal carcinoma.
Trends in early onset colorectal cancer–related mortality among adults in the United States from 1999-2020. Multi-site blinded validation of a deep learning approach for clinical-grade MSI/dMMR ...